Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
86 stocks in the Americas match these filters · market cap, largest first. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| JATT | JATT II Acquisition Corp. | Oncology | $97.15M | $12.46 | −47.58% | +11.80% |
| ACRV | Acrivon Therapeutics, Inc. | Oncology | $93.42M | $2.18 | −38.76% | +39.74% |
| MAIA | MAIA Biotechnology, Inc. | Oncology | $85.78M | $1.41 | −55.80% | +10.16% |
| CTOR | Citius Oncology, Inc. | Oncology |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| $85.68M |
| $0.81 |
| −64.00% |
| +45.70% |
| VRCA | Verrica Pharmaceuticals Inc. | Oncology | $83.66M | $4.94 | −49.70% | −7.66% |
| CRDF | Cardiff Oncology, Inc. | Oncology | $79.35M | $1.02 | −69.18% | +21.43% |
| ELTX | Elicio Therapeutics, Inc. | Oncology | $79.11M | $3.01 | −81.19% | +0.33% |
| APLM | Apollomics, Inc. | Oncology | $76.75M | $26.50 | −37.08% | +47.22% |
| OSTX | OS Therapies Incorporated | Oncology | $76.68M | $1.65 | −35.80% | +7.84% |
| PLRX | Pliant Therapeutics, Inc. | Oncology | $73.69M | $1.14 | −41.54% | +5.56% |
| XBIT | XBiotech Inc. | Oncology | $70.43M | $2.30 | −36.29% | +1.77% |
| PMVP | PMV Pharmaceuticals, Inc. | Oncology | $69.76M | $1.31 | −30.59% | +10.59% |
| BOLD | Boundless Bio, Inc. | Oncology | $67.33M | $2.94 | −7.08% | +18.55% |
| RNXT | RenovoRx, Inc. | Oncology | $64.08M | $1.42 | −8.97% | +47.15% |
| HRTX | Heron Therapeutics, Inc. | Oncology | $61.34M | $0.32 | −79.55% | −29.76% |
| XLO | Xilio Therapeutics, Inc. | Oncology | $59.75M | $9.08 | −28.73% | −0.11% |
| IMMP | Immutep Limited | Oncology | $56.28M | $0.38 | −89.18% | +0.50% |
| TIL | Instil Bio, Inc. | Oncology | $51.54M | $7.81 | −76.92% | +9.23% |
| IBO | Impact BioMedical Inc. | Oncology | $49.62M | $0.46 | −44.55% | +6.53% |
| BKHA | Black Hawk Acquisition Corporation | Oncology | $49.39M | $11.89 | −9.24% | −1.74% |
| HOWL | Werewolf Therapeutics, Inc. | Oncology | $42.93M | $0.89 | −62.61% | +96.47% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | Oncology | $42.19M | $1.92 | −82.53% | −72.92% |
| CNTX | Context Therapeutics Inc. | Oncology | $40.00M | $0.44 | −87.97% | −30.00% |
| ATNM | Actinium Pharmaceuticals, Inc. | Oncology | $33.88M | $1.08 | −40.20% | +26.46% |
| BCTX | BriaCell Therapeutics Corp. | Oncology | $32.80M | $3.77 | −74.32% | +6.20% |
| KYNB | Kyntra Bio, Inc. | Oncology | $32.80M | $8.10 | −35.71% | +14.89% |
| BCT.TO | BriaCell Therapeutics Corp. | Oncology | $32.32M | 5.14 CAD | −74.80% | +1.98% |
| BYSI | BeyondSpring Inc. | Oncology | $29.61M | $0.72 | −70.48% | −38.44% |
| MDNA.TO | Medicenna Therapeutics Corp. | Oncology | $29.00M | 0.47 CAD | −76.14% | +36.23% |
| EVAX | Evaxion A/S | Oncology | $28.36M | $3.35 | −72.43% | +15.92% |
| LTRN | Lantern Pharma Inc. | Oncology | $27.87M | $2.18 | −53.65% | −21.86% |
| NXTC | NextCure, Inc. | Oncology | $27.05M | $5.91 | −62.45% | +15.43% |
| PSTV | Plus Therapeutics Inc | Oncology | $26.64M | $3.84 | −83.67% | +2.90% |
| ATOS | Atossa Therapeutics, Inc. | Oncology | $26.35M | $2.68 | −86.15% | +13.56% |
| CVM | CEL-SCI Corporation | Oncology | $26.03M | $1.48 | −89.02% | +25.42% |
| MRKR | Marker Therapeutics, Inc. | Oncology | $25.34M | $1.52 | −38.21% | +24.59% |
| CLRB | Cellectar Biosciences, Inc. | Oncology | $24.01M | $2.54 | −61.04% | +4.96% |
| BFRI | Biofrontera Inc. | Oncology | $22.43M | $1.51 | −2.58% | +43.81% |
| CCM | Concord Medical Services Holdings Limited | Oncology | $21.49M | $4.95 | −29.08% | +9.76% |
| ABVC | ABVC BioPharma, Inc. | Oncology | $21.32M | $0.80 | −76.47% | −21.58% |
| ALLR | Allarity Therapeutics, Inc. | Oncology | $21.16M | $1.33 | −43.40% | +8.13% |
| RADX | Radiopharm Theranostics Limited | Oncology | $19.55M | $2.48 | −84.74% | −32.24% |
| TPST | Tempest Therapeutics, Inc. | Oncology | $18.36M | $1.11 | −90.92% | +18.72% |
| CTXR | Citius Pharmaceuticals, Inc. | Oncology | $16.57M | $0.60 | −72.43% | +16.77% |
| MDCX | Medicus Pharma Ltd. | Oncology | $16.26M | $0.26 | −91.44% | −17.92% |
| INTS | Intensity Therapeutics, Inc. | Oncology | $15.98M | $4.90 | −88.75% | +7.11% |
| LSTA | Lisata Therapeutics, Inc. | Oncology | $15.68M | $1.74 | −65.68% | +20.83% |
| AKTX | Akari Therapeutics, Plc | Oncology | $14.54M | $7.87 | −84.13% | −6.97% |
| PHIO | Phio Pharmaceuticals Corp. | Oncology | $13.82M | $1.17 | −72.08% | +11.43% |
| GTBP | GT Biopharma, Inc. | Oncology | $13.52M | $0.30 | −78.12% | −10.27% |
| BLRX | BioLineRx Ltd. | Oncology | $12.45M | $2.85 | −37.50% | +1.06% |
| PDSB | PDS Biotechnology Corporation | Oncology | $12.40M | $0.22 | −85.71% | −68.04% |
| MBRX | Moleculin Biotech, Inc. | Oncology | $11.90M | $0.61 | −96.12% | −72.10% |
| TOVX | Theriva Biologics, Inc. | Oncology | $10.90M | $0.24 | −72.66% | +11.95% |
| APRE | Aprea Therapeutics, Inc. | Oncology | $10.14M | $0.95 | −44.12% | +51.98% |
| LNAI | Lunai Bioworks Inc. | Oncology | $9.97M | $2.20 | −89.62% | −1.35% |
| XBIO | Xenetic Biosciences, Inc. | Oncology | $8.93M | $3.82 | −72.58% | +52.80% |
| IMNN | Imunon, Inc. | Oncology | $8.92M | $1.66 | −76.15% | +8.50% |
| CNSP | CNS Pharmaceuticals, Inc. | Oncology | $8.48M | $5.80 | −45.22% | +14.40% |
| AIM | AIM ImmunoTech Inc. | Oncology | $7.73M | $0.25 | −91.21% | +1.60% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.